Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors
Abstract is missing (Short communication)
Saved in:
Main Authors: | Chul Hwan Bang (Author), Hyun Ju Oh (Author), Yeong Ho Kim (Author), Jin-Hyung Jung (Author), Ji Hyun Lee (Author), Young Min Park (Author), Ju Hee Han (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
by: Tzu-Chang Wang, et al.
Published: (2015) -
Treatment efficacy and patient satisfaction of ustekinumab compared with tumor necrosis factor-alpha inhibitors in Chinese patients with moderate-to-severe psoriasis: a real-world study
by: Bin Guo, et al.
Published: (2024) -
Ustekinumab: differential use in psoriasis
by: Uhlenhake EE, et al.
Published: (2011) -
Ineffectiveness of tumor necrosis factor-α blockers and ustekinumab in a case of type IV pityriasis rubra pilaris
by: Vito Di Lernia, et al.
Published: (2015) -
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
by: Bayanne Olabi, et al.
Published: (2020)